We are live on
!
Find out more
CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.67B
1-Year Est. Return
89%
This Fund
S&P 500
This Quarter
Est. Return
+22.56%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$295M
AUM Growth
+$46.7M
(+19%)
Cap. Flow
+$5.84M
Cap. Flow
% of AUM
1.98%
Top 10 Holdings %
Top 10 Hldgs %
32.39%
Holding
456
New
65
Increased
317
Reduced
38
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$6.09M |
| 2 |
PayPal
PYPL
|
+$4.84M |
| 3 |
STAAR Surgical
STAA
|
+$3.72M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$3.18M |
| 5 |
Microsoft
MSFT
|
+$2.94M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$7.85M |
| 2 |
iQIYI
IQ
|
+$7.2M |
| 3 |
ON Semiconductor
ON
|
+$4.1M |
| 4 |
Apple
AAPL
|
+$2.75M |
| 5 |
uniQure
QURE
|
+$2.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.43% |
| 2 | Consumer Discretionary | 23.55% |
| 3 | Healthcare | 18.31% |
| 4 | Communication Services | 8.83% |
| 5 | Financials | 4.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PSTX
401
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $3.58K | ﹤0.01% |
1,164
+290
| +33% | +$1.74K |
|
|
TVRD
402
Tvardi Therapeutics
TVRD
$22.1M
| $3.57K | ﹤0.01% |
20
+5
| +33% | +$1.67K |
|
403
Foghorn Therapeutics
FHTX
$394M
| $3.51K | ﹤0.01% |
566
+141
| +33% | +$923 |
|
404
Immuneering
IMRX
$328M
| $3.48K | ﹤0.01% |
358
+90
| +34% | +$511 |
|
|
GBIO
405
DELISTED
Generation Bio
GBIO
| $3.47K | ﹤0.01% |
81
+21
| +35% | +$1.02K |
|
406
MeiraGTx Holdings
MGTX
$1.2B
| $3.4K | ﹤0.01% |
657
+202
| +44% | +$1.4K |
|
407
Adicet Bio
ACET
$77.3M
| $3.35K | ﹤0.01% |
36
+9
| +33% | +$1.13K |
|
|
NBP
408
NovaBridge Biosciences American Depositary Shares
NBP
$216M
| $3.2K | ﹤0.01% |
925
+372
| +67% | +$1.8K |
|
|
CMPS
409
Compass Pathways
CMPS
$1.97B
| $3.19K | ﹤0.01% |
321
+81
| +34% | +$746 |
|
|
GRTS
410
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $3.14K | ﹤0.01% |
1,130
+283
| +33% | +$809 |
|
|
EXAI
411
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $3.11K | ﹤0.01% |
587
+220
| +60% | +$1.49K |
|
412
Xeris Biopharma Holdings
XERS
$1.55B
| $3K | ﹤0.01% |
1,842
+461
| +33% | +$577 |
|
413
PMV Pharmaceuticals
PMVP
$67.2M
| $2.95K | ﹤0.01% |
618
+154
| +33% | +$1.08K |
|
|
OPTN
414
DELISTED
OptiNose
OPTN
| $2.91K | ﹤0.01% |
101
+27
| +36% | +$719 |
|
|
KZR
415
DELISTED
Kezar Life Sciences
KZR
| $2.9K | ﹤0.01% |
93
+23
| +33% | +$1.33K |
|
416
UroGen Pharma
URGN
$2.39B
| $2.89K | ﹤0.01% |
313
+79
| +34% | +$727 |
|
417
Cartesian Therapeutics
RNAC
$263M
| $2.88K | ﹤0.01% |
69
+17
| +33% | +$799 |
|
418
Quantum-Si Incorporated
QSI
$182M
| $2.86K | ﹤0.01% |
1,624
+406
| +33% | +$801 |
|
419
Altimmune
ALT
$570M
| $2.82K | ﹤0.01% |
668
+169
| +34% | +$2.01K |
|
420
Century Therapeutics
IPSC
$353M
| $2.77K | ﹤0.01% |
799
+200
| +33% | +$878 |
|
421
Inovio Pharmaceuticals
INO
$79.6M
| $2.77K | ﹤0.01% |
282
+71
| +34% | +$1.21K |
|
|
CNTA
422
DELISTED
Centessa Pharmaceuticals
CNTA
| $2.74K | ﹤0.01% |
712
+179
| +34% | +$655 |
|
423
ALX Oncology
ALXO
$278M
| $2.5K | ﹤0.01% |
552
+138
| +33% | +$1.04K |
|
424
Annexon
ANNX
$873M
| $2.49K | ﹤0.01% |
646
+162
| +33% | +$891 |
|
425
Fulcrum Therapeutics
FULC
$284M
| $2.38K | ﹤0.01% |
836
+307
| +58% | +$2.75K |
|
Similar funds
HA
JPM
CPO
LCI
GWM
JIP
RMC
GACM
China Universal Asset Management Company's Q1 2023 Portfolio in Review
As of Q1 2023, China Universal Asset Management Company held 456 positions worth $295M, up 19% from $249M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
China Universal Asset Management Company's Q1 2023 filing shows 65 new, 317 increased, 38 reduced and 9 closed positions. Its largest new stake was Baidu: 20,500 shares worth $3.09M. The largest sale was Pinduoduo, an estimated $7.85M.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- China Universal Asset Management Company's largest Q1 2023 buy was Baidu: 20,500 shares worth $3.09M.
- China Universal Asset Management Company added most to NVIDIA in Q1 2023, an estimated $6.09M increase.
- China Universal Asset Management Company's biggest Q1 2023 reduction was Pinduoduo, cutting an estimated $7.85M.
- China Universal Asset Management Company fully exited Tower Semiconductor in Q1 2023, selling an estimated $1.94M.
- China Universal Asset Management Company's ten largest holdings make up 32% of its $295M portfolio in Q1 2023.
- China Universal Asset Management Company opened 65 new positions and closed 9 in Q1 2023.
- China Universal Asset Management Company's portfolio value rose 19% quarter-over-quarter to $295M.
Based on China Universal Asset Management Company's 13F filing for Q1 2023, filed 28 Apr 2023.